(Q35107086)

6 August 2017

Plasma sCD14 as a biomarker to predict pulmonary exacerbations in cystic fibrosis (English)

1 reference

6 August 2017

0 references

0 references

Bradley S Quon

1

1 reference

6 August 2017

David A Ngan

2

1 reference

6 August 2017

Pearce G Wilcox

3

1 reference

6 August 2017

S F Paul Man

4

1 reference

6 August 2017

Don D Sin

5

1 reference

6 August 2017

language of work or name

English

0 references

publication date

20 February 2014

1 reference

6 August 2017

1 reference

6 August 2017

9

1 reference

6 August 2017

2

1 reference

6 August 2017

e89341

1 reference

Creative Commons Attribution 4.0 International

6 August 2017

start time

20 February 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Systematic review of blood biomarkers in cystic fibrosis pulmonary exacerbations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3930718

Pulmonary exacerbation: towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3930718

Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3930718

Expression, regulation and clinical significance of soluble and membrane CD14 receptors in pediatric inflammatory lung diseases.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3930718

Adult cystic fibrosis patients with and without infective exacerbations and their factor XII levels

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3930718

Quality of life in young people with cystic fibrosis: effects of hospitalization, age and gender, and differences in parent/child perceptions

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3930718

Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3930718

CD14 is an acute-phase protein

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3930718

Predictive 5-year survivorship model of cystic fibrosis

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3930718

CD14 and innate recognition of bacteria.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3930718

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3930718

Inflammatory markers in cystic fibrosis

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3930718

CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3930718

Impact of recent pulmonary exacerbations on quality of life in patients with cystic fibrosis.

9 July 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0089341

Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0089341

One-year outcome after severe pulmonary exacerbation in adults with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0089341

The impact of treatment of pulmonary exacerbations on the health-related quality of life of patients with cystic fibrosis: does hospitalization make a difference?

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3930718

Cystic fibrosis: inflammatory response to infection with Burkholderia cepacia and Pseudomonas aeruginosa

27 September 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0089341

Human neutrophil lipocalin, a highly specific marker for acute exacerbation in cystic fibrosis

21 January 2018

1 reference

12 December 2020

Standardization of spirometry--1987 update. Statement of the American Thoracic Society

1 reference

12 December 2020

Increased Circulating Soluble Cd14 Is Associated With High Mortality In Gram-Negative Septic Shock

1 reference

12 December 2020

Increased Serum Concentration of Soluble CD14 Is a Prognostic Marker in Gram-Positive Sepsis

1 reference

12 December 2020

Serum matrix metalloproteinases in adult CF patients: Relation to pulmonary exacerbation

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0089341

Identifiers

DOI

1 reference

6 August 2017

0 references

1 reference

6 August 2017

1 reference